Cutler Group LP Tff Pharmaceuticals, Inc. Transaction History

Cutler Group LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 18, 2022	SELL	$6.86 - $9.65 $1,907 - $2,682	-278 Reduced 21.75%	1,000 $8,000
Q3 2021 Oct 26, 2021	SELL	$7.21 - $10.49 $8,652 - $12,588	-1,200 Reduced 48.43%	1,278 $9,000
Q2 2021 Jul 19, 2021	BUY	$8.48 - $13.61 $11,685 - $18,754	1,378 Added 125.27%	2,478 $23,000
Q1 2021 Apr 26, 2021	SELL	$12.96 - $19.75 $90,720 - $138,250	-7,000 Reduced 86.42%	1,100 $14,000
Q4 2020 Jan 21, 2021	BUY	$12.74 - $18.49 $95,550 - $138,675	7,500 Added 1250.0%	8,100 $115,000
Q3 2020 Oct 27, 2020	BUY	$5.86 - $18.47 $3,516 - $11,082	600 New	600 $11,000

Ticker TFFP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,477,800
Market Cap $8.92M
Description
TFF Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing drug products based on its patented Thin Film Freezing (TFF) technology platform in the United States and Australia. It intends to focus on the development of inhaled dry powder drugs for the treatment of pulmonary diseases and condit...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.